Genmab A/S
Sector: Companies & groupsHQ: DENMARK
EU Lobbying Profiles
Genmab A/S
Register: EU_TRANSPARENCY_REGISTER
Declared Spend (Max)
€49,999
Regulatory Meetings
Exchange of views on the Biotech Act proposal adopted on 16 December 2025 and the Health Technology Assessment Regulation
Met with Maya Matthews (EU)
Discuss the newly released Health Package, companion diagnostics under the ongoing review of the IVDR, the coherence between the Artificial Intelligence (AI) Act and sector-specific health legislation, the Biotech Act
Met with Rainer Becker (EU)
Government Procurement
No government procurement contracts found.
Executive Insider Trades
No executive insider trades reported.